英文摘要 |
Itch is the main chief complaint in patients visiting dermatologic clinics and has the ability to deeply impair life quality. Itch results from activation of cutaneous nerve endings by noxious stimuli such as inflammatory mediators, neurotransmitters and neuropeptides, causing itch signal transduction from peripheral skin, through the spinal cord and thalamus, to the brain cortex. While some inflammatory skin diseases such as lupus erythematosus, cellulitis, and pityriasis lichenoides may or may not cause itch, others such as psoriasis and atopic dermatitis cause moderate-to-severe itch in a majority of the patients. It is important to find the key mediators that cause such differences. On the other hand, primarily noninflammatory diseases, such as uremic pruritus, cause itch through certain pruritogens without causing skin inflammatory change. Meanwhile, there is evidence that pruritogens are not only responsible for eliciting pruritus, but also interact with immune cells and act as inflammatory mediators, which exacerbate disease activities. The understanding of these mediators can provide targeted therapies for inflammatory and noninflammatory itch in common itching skin diseases. |